Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
2.080
+0.080 (4.00%)
At close: Oct 5, 2026, 4:00 PM EDT
2.140
+0.060 (2.88%)
After-hours: Oct 5, 2026, 7:45 PM EDT

Cabaletta Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
353211111973270107
Market Cap Growth
66.91%90.01%-88.59%260.85%151.03%-64.23%
Enterprise Value
15377-57813184-12
Last Close Price
2.082.192.2722.709.253.79

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.661.880.734.122.580.91
P/TBV Ratio
1.671.880.734.122.580.91

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.120.240.100.020.05-
Net Debt / Equity Ratio
-0.95-0.95-0.97-1.00-0.97-1.04
Net Debt / EBITDA Ratio
1.080.621.203.231.922.68
Net Debt / FCF Ratio
1.290.811.644.362.083.47
Quick Ratio
5.642.666.0515.0811.2314.59
Current Ratio
5.792.776.1515.2911.4714.86
Return on Equity (ROE)
-93.20%-126.98%-59.64%-39.73%-47.62%-40.69%
Return on Assets (ROA)
-48.19%-61.49%-35.66%-25.18%-27.81%-24.02%
Return on Capital Employed (ROCE)
-85.60%-149.90%-79.20%-31.40%-50.40%-39.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-51.42%-79.62%-104.43%-6.96%-19.65%-43.11%
FCF Yield
-43.73%-62.76%-81.51%-5.58%-18.12%-32.85%
Buyback Yield / Dilution
-121.83%-61.34%-20.95%-39.54%-14.01%-11.20%
SEC Filings: 10-K · 10-Q